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LETTERS TO THE EDITOR
Peripartum Cardiomyopathy-I
The review of peripartum cardiomyopathy by O'Connell and col-
leagues ( I) is an excellent state-of-the-art presentation. I would
take exception, however, to the statement of a type that occurs
much too frequently, even in carefully peer-reviewed papers:
" . . . does not reach statistical significance because of the small
sample size" (emphasis mine). What the t test (here, p > 0.05)
implied was that the particular result could be due to chance rather
than being a " true" result. Moreover, tests of significance take
the sample size into account. Therefore , " because of the small
sample size" would presuppose that they had a " true" trend ,
which is not defensible by these rules . Given the kind of patients
in the study , clinically one expects that the authors ' prediction
might be correct. But when one looks at the small number of
subjects (six versus eight) the nonsignificant trend could easily be
reversed. Although the 0.05 probability level is not holy, if we
utilize a statistical test , we should accept it for what it tells us.
Here a given result has not exceeded an "accepted" threshold for
its being due to chance. (Of course, it would be preferabl e to add
confidence intervals, but that is another question).
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Peripartum Cardiomyopathy-II
A provocative finding of O'Connell et a!. (I) was that 29% of
patients with peripartum cardiomyopathy had histologic evidence
of myocarditis compared with a 9% incidence of histologic my-
ocarditis in their patients with idiopathic dilated cardiomyopathy.
The authors recognize that com parison of the two patient groups
may be problematic because they were not age- and sex-matched.
In addition , the percent of patients with idiopathic cardiomyopathy
who had a myocardial biopsy early in their clinical course was not
report ed. The duration of symptoms in this group was much greater
than in the peripartum cardiomyopathy group (19 versus 4 months).
It is possible that few patients with idiopathic dilated cardio-
myopathy had an early myocardi al biopsy as did all peripartum
patients with myocarditis. In addition, a nonperip artum patient
with new symptoms of heart failure of uncertain etiology and a
cardiac biopsy demonstrating myocarditis would likely be diag-
nosed as having acute viral myocarditis. A resultant cardio-
myopathy may be classified as postmyocarditic rather than idio-
pathic. These factors may also limit meaningful comparison of the
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incidence of histologic myocardit is in the peripartum cardio-
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Reply
As mentioned in the report , it was not possible to establish an age-
and sex-matched control group because the majority of women
who presented with idiopathic dilated cardiomyopathy during child-
bearing years did so in the puerperium and therefore represent
patients with peripartum cardiomyopathy. In our series all patients
presenting with angiograph ically proven idiopathic dilated cardio-
myopath y were classified as such for statistical analysis even if
the biopsy showed myocarditis. The comparison between the
two groups was an attempt to distinguish clinical or hemodynamic
factors. We were unable , however , to identify unique character-
istics of the study group other than age, sex and durat ion of symp-
toms. The duration of symptoms (19 ± 18.4 months in idiopathic
dilated cardiomyopathy and 4.1 ± 7.7 months in peripartum car-
diomyopathy ) differed because women with peripartum cardio-
myopathy were usually under close physician surveillance for their
obstetric care at the time congestive heart failure developed and
patients with idiopathic dilated cardiomyopathy tended to seek
medical care later in the course of their illness . Taliercio raises a
very important point in that the incidence of biopsy-proven my-
ocarditis in patients with idiopathic dilated cardiomyopathy may
be falsely low owing to this time delay from the onset of symptoms
to diagnostic eva luation. If the myocardial biopsy was performed
earlier in the course of the illness , perhaps the incidence of my-
ocarditis would be higher. It is not likely that diagnostic studies
would ever be performed as early in idiopathic dilated cardio-
myopathy as they are in peripartum cardiomyopathy. Recent re-
ports (I ) suggest that biopsy should be performed to identify my-
ocarditis in patients with heart failure of recent onset defined as
less than 6 months duration , 2 months longer than the mean du-
ration of symptoms in peripartum cardiomyopathy. Although a
high incidence of myocard itis similar to that seen in peripartum
cardiomyopathy may in fact occur in other subsets of cardio-
myopathy, the concept that early diagnosis will result in a higher
yield of biopsy remains speculative.
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